The available studies differ in drug type, dose, indication, timing of exposure, comparator structure, and baseline maternal metabolic risk, and the number of exposed pregnancies remains insufficient to exclude uncommon but clinically important harms (132, 133)
Gorenshtein A, Liba T, Leibovitch L, Stern S, Stern Y
[DOI] [PMC free article] [PubMed] [Google Scholar] Lewis J
Factors that may be preventing you from losing belly fat while using tirzepatide (Mounjaro) include time and persistence (it takes time to lose fat around the abdomen), under-dosage (having excessive calorie intake even if from healthy foods), absence of physical activity, high stress or sleep deprivation (leading to increased cortisol), and many other possibilities
Lone Star Center for Health and Wellness ensures that patients are fully educated on how to recognize these signs and provides support throughout the treatment process
They were found to have significant HbA1c, and weight reduction compared to placebo in patients with diabetes and obesity respectively
02105-1/asset/8468e457-0c7f-4e4c-9b6d-2202dbefa9cb/main.assets/gr1_lrg.jpg)
